HE, Leicheng. SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits. Highlights in Science, Engineering and Technology, [S. l.], v. 74, p. 1717–1722, 2023. DOI: 10.54097/m9vm2798. Disponível em: https://drpress.org/ojs/index.php/HSET/article/view/16046. Acesso em: 8 jun. 2026.